Cover image of the article: The Role of Interferon Gamma Gene Polymorphism (+874A/T, +2109A/G, and -183G/T) in Response to Treatment Among Hepatitis C Infected Patients in Fars Province, Southern Iran

Image Credit:Hepat Mon

The Role of Interferon Gamma Gene Polymorphism (+874A/T, +2109A/G, and -183G/T) in Response to Treatment Among Hepatitis C Infected Patients in Fars Province, Southern Iran

Authors

Jamal Sarvari1, Hossin Norozian1, Mohamad Reza Fattahi2, Neda Pirbonyeh1, Afagh MoattariAfagh Moattari ORCID1,*
1Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
2Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
*Corresponding Author: Department of Bacteriology and Virology, Shiraz University of Medical Sciences, Shiraz, IR Iran. Tel/Fax: +98-7112304356, moattaria@sums.ac.ir. Email: moattaria@sums.ac.ir

Hepatitis Monthly:Vol. 14, issue 1; 14476
Published online:Jan 22, 2014
Article type:Research Article
Received:Aug 26, 2013
Accepted:Oct 25, 2013
How to Cite:Sarvari J, Norozian H, Fattahi MR, Pirbonyeh N, Moattari A. The Role of Interferon Gamma Gene Polymorphism (+874A/T, +2109A/G, and -183G/T) in Response to Treatment Among Hepatitis C Infected Patients in Fars Province, Southern Iran. Hepat Mon. 2013;14(1):14476. doi: https://doi.org/10.5812/hepatmon.14476

Abstract

Background:

Hepatitis C virus (HCV) infection as a worldwide health problem is associated with cirrhosis and hepatocellular carcinoma. With current treatment regimen, pegylated interferon (PEG-IFN) plus ribavirin, sustain virological response (SVR) is achieved in only 50% of infected individuals. In HCV infection, an inappropriate ratio of cytokines may affect the benefit of antiviral therapy. Given the polymorphisms in regulatory regions of cytokines genes may influence cytokines production.

Objectives:

We aimed to investigate both the frequency of genotypes and alleles of interferon gamma (IFN-?) gene at +874A/T, +2109A/G, and -183G/T loci in HCV-infected patients and their associations with response to therapy.

Patients and Methods:

A total of 158 patients were included and treated with PEG-IFN plus ribavirin. The presence of HCV infection in patients was confirmed by reverse transcription polymerase chain reaction, and genomic DNA was extracted from peripheral leukocytes using salting out method. IFN-? gene polymorphisms were identified by polymerase chain reaction using sequence specific primers and restriction fragment length polymorphism analysis on genomic DNA.

Results:

Of 158 patients, 110 (69.5%) subjects achieved SVR and 48 (30.5%) subjects did not respond to therapy. The frequency of AA genotype (P = 0.001; OR: 11.2; CI: 2.26-63.21) and A allele (P = 0.01; OR: 3.23; CI: 1.23 8.56) of IFN-? gene at +2109 locus were significantly different between the responder and non-responder subjects infected with genotype 1. Regardless of HCV genotype, the frequency of AG genotype was also higher in responder group than those who did not respond to therapy (P = 0.041; OR: 05.05; CI: 1.05-33.25)). In case of IFN-? gene at +874 locus, there was no difference in genotypes and alleles frequencies between the responder and non-responder subjects infected with HCV genotypes 1 and 3. Haplotype analysis showed no association between haplotypes and response to therapy. All participants had G/T genotype at -183 locus.

Conclusions:

Our findings indicate that heterogeneity at +2109 locus of IFN-? gene but not at +874 locus could interfere with successful therapy in patients infected with HCV genotype 1.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

7
Sep
2018
Association between interleukin 10 polymorphisms (-592C/A and - 819 C/T) with response to treatment in Iranian patients with hepatitis C virus

Association between interleukin 10 polymorphisms (-592C/A and - 819 C/T) with response to treatment in Iranian patients with hepatitis C virus

Farahnaz Bineshian,
Sanam Mohsenin,
Zohreh Sharifi

Bineshian F, Mohsenin S, Sharifi Z. Association between interleukin 10 polymorphisms (-592C/A and - 819 C/T) with response to treatment in Iranian patients with hepatitis C virus. koomesh. 2018;20(3):e152984. doi:

2
Jun
2020
The Study of IFNL3 Gene Rs12979860 Polymorphism in the Hepatitis C Virus Patients and Healthy Population in Tehran Province, Iran

The Study of IFNL3 Gene Rs12979860 Polymorphism in the Hepatitis C Virus Patients and Healthy Population in Tehran Province, Iran

Mohsen Koolivand,
Zeinab Allamehzadeh,
Ali Ahmadi,
Ramezan Ali Taheri,
Kazem Hassanpour,
Afshin Zeini
,et al.

Koolivand M, Allamehzadeh Z, Ahmadi A, Taheri RA, Hassanpour K, et al. The Study of IFNL3 Gene Rs12979860 Polymorphism in the Hepatitis C Virus Patients and Healthy Population in Tehran Province, Iran. Jundishapur J Microbiol. 2020;13(5):e95798. doi: https://doi.org/10.5812/jjm.95798

21
Aug
2016
Interferon Gamma Gene Polymorphism (+874 T > A) and Chronic Hepatitis B in the Population of Gorgan, North-Eastern Iran

Interferon Gamma Gene Polymorphism (+874 T > A) and Chronic Hepatitis B in the Population of Gorgan, North-Eastern Iran

Nadia Ghasemian,
Majid Shahbazi

Ghasemian N, Shahbazi M. Interferon Gamma Gene Polymorphism (+874 T > A) and Chronic Hepatitis B in the Population of Gorgan, North-Eastern Iran. Jundishapur J Microbiol. 2016;9(8):e33639. doi: https://doi.org/10.5812/jjm.33639

6
Nov
2012
Polymorphisms within the Promoter Region of the Gamma Interferon (IFN-?) Receptor1 Gene are Associated with the Susceptibility to Chronic HBV Infection in an Iranian Population

Polymorphisms within the Promoter Region of the Gamma Interferon (IFN-?) Receptor1 Gene are Associated with the Susceptibility to Chronic HBV Infection in an Iranian Population

Sayyad Khanizadeh,
Mehrdad Ravanshad,
Seyed Reza Reza Mohebbi,
Hamed Naghoosi,
Mohamad Ebrahim Abrahim Tahaei,
Seyed Dawood Dawood Mousavi Nasab
,et al.

Khanizadeh S, Ravanshad M, Mohebbi SR, Naghoosi H, Tahaei ME, et al. Polymorphisms within the Promoter Region of the Gamma Interferon (IFN-?) Receptor1 Gene are Associated with the Susceptibility to Chronic HBV Infection in an Iranian Population. Hepat Mon. 2012;12(11):7283. doi: https://doi.org/10.5812/hepatmon.7283

3
May
2016
The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C

The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C

Danesh Kadjbaf,
Maryam Keshvari,
Seyed Moayed Alavian,
Ali Pouryasin,
Bita Behnava,
Shima Salimi
,et al.

Kadjbaf D, Keshvari M, Alavian SM, Pouryasin A, Behnava B, et al. The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C. Hepat Mon. 2016;16(6):e37011. doi: https://doi.org/10.5812/hepatmon.37011

More by these authors

Jamal SarvariPubMedScholar
Hossin NorozianPubMedScholar
Mohamad Reza FattahiPubMedScholar
Neda PirbonyehPubMedScholar
Afagh MoattariPubMedScholar
Share
Cited by
Metrics